Avadel Pharmaceuticals Plc is a biopharmaceutical company that focuses on the development of products for the treatment of narcolepsy
Avadel Pharmaceuticals Plc is a biopharmaceutical company that focuses on the development of products for the treatment of narcolepsy. Its marketed product Lumryz is an FDA-approved, once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. The company develops products using proprietary polymer-based technologies.